Regeneron is the second pharma group to sign up for access to data from a remote study run by health technology firm Koneksa that is exploring the use of digital biomarkers to track patients with ...

When the GPR75 researh was published, Regeneron's chief scientific officer George Yancopoulos, described the mutations as a "genetic superpower" that "provides hope in combating global health ...

2025Goldman Sachs 46th Annual Global Healthcare Conference at 10 TARRYTOWN, N.Y., April 18, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S ...

We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished ...

Americans got a fly-on-the-wall view of a group working together to execute ... leading edge of change that is disrupting the U.S.-led global order. Henry M.

In the first quarter, the FDA granted Intellia the RMAT designation for nex-z for the treatment of ATTR with cardiomyopathy, which follows prior RMAT designations received for nex-z for ATTR with ...

Myeloma Action Month is an annual global awareness campaign that takes ... Myeloma 101: The Big Picture Perspective with Q&A; Navigating Insurance and Medical Bills, and much more.

billboard global 200 the week's most popular songs based on streaming and sales activity from over 200 territories around the world — including the united states — as tracked by luminate. the ...

The economic strain of recent years has underscored a fundamental truth: isolationism cannot insulate nations from global crises ... Liaoning Province. The views don't necessarily reflect those ...

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...